Valuation: Biogen Inc.

Capitalization 27.13B 23.39B 21.12B 20.26B 36.95B 2,493B 38.67B 250B 100B 1,196B 102B 99.66B 4,276B P/E ratio 2026 *
15.6x
P/E ratio 2027 * 14.7x
Enterprise value 27.08B 23.35B 21.08B 20.23B 36.88B 2,489B 38.6B 249B 99.84B 1,194B 102B 99.48B 4,269B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.55x
Free-Float
85.5%
Yield 2026 *
-
Yield 2027 * -
1 day-1.71%
1 week-3.62%
Current month-3.62%
1 month-8.11%
3 months+1.97%
6 months+31.42%
Current year+5.05%
1 week 181.24
Extreme 181.24
190.99
1 month 181.24
Extreme 181.24
201
Current year 160.36
Extreme 160.3645
202.41
1 year 110.04
Extreme 110.035
202.41
3 years 110.04
Extreme 110.035
319.76
5 years 110.04
Extreme 110.035
468.55
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer 59 02/10/2023
Director TitleAgeSince
Chairman 66 26/06/2023
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Change 5d. change 1-year change 3-years change Capi.($)
-1.71%-3.62%+22.94%-30.21% 27.13B
-0.66%-2.79%+7.40%-1.81% 77.98B
-2.68%-0.52%+33.16%+214.46% 55.42B
-0.18%+64.40%+64.40%+64.40% 51.24B
-0.15%-0.33%-43.67%-50.73% 49.37B
-2.43%-1.96%+47.49%-62.76% 20.74B
-1.43%-5.26%+35.53%+28.99% 19.09B
+6.18%-2.12%+107.21%+97.16% 18.48B
-1.21%-4.75%+27.92%+56.07% 14.15B
+0.27%-8.47%+1.22%+897.33% 13.43B
Average -0.40%-3.74%+30.36%+121.29% 34.7B
Weighted average by Cap. -0.69%-3.19%+23.73%+73.80%

Financials

2026 *2027 *
Net sales 9.42B 8.12B 7.33B 7.04B 12.83B 866B 13.43B 86.68B 34.73B 415B 35.36B 34.6B 1,485B 9.35B 8.07B 7.28B 6.99B 12.74B 860B 13.33B 86.07B 34.48B 412B 35.11B 34.36B 1,474B
Net income 1.86B 1.6B 1.45B 1.39B 2.53B 171B 2.65B 17.11B 6.85B 81.93B 6.98B 6.83B 293B 2.01B 1.73B 1.56B 1.5B 2.74B 185B 2.86B 18.49B 7.41B 88.55B 7.54B 7.38B 317B
Net Debt -46.71M -40.27M -36.35M -34.88M -63.6M -4.29B -66.56M -430M -172M -2.06B -175M -172M -7.36B -3.26B -2.81B -2.53B -2.43B -4.43B -299B -4.64B -29.96B -12B -143B -12.22B -11.96B -513B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/03/26 184.87 $ -1.71% 772,906
05/03/26 188.08 $ -0.98% 893,331
04/03/26 189.94 $ +3.22% 952,927
03/03/26 184.02 $ -2.14% 1,049,925
02/03/26 188.05 $ -1.97% 691,597
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
184.87USD
Average target price
205.67USD
Spread / Average Target
+11.25%

Quarterly revenue - Rate of surprise